APA

Romaguera J. E., Fayad L., Rodriguez M. A., Broglio K. R., Hagemeister F. B., Pro B., McLaughlin P., Younes A., Samaniego F., Goy A., Sarris A. H., Dang N. H., Wang M., Beasley V., Medeiros L. J., Katz R. L., Gagneja H., Samuels B. I., Smith T. L. & Cabanillas F. F. (20051102). High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Romaguera Jorge E, Fayad Luis, Rodriguez Maria A, Broglio Kristine R, Hagemeister Frederick B, Pro Barbara, McLaughlin Peter, Younes Anas, Samaniego Felipe, Goy Andre, Sarris Andreas H, Dang Nam H, Wang Michael, Beasley Virginia, Medeiros L Jeffrey, Katz Ruth L, Gagneja Harish, Samuels Barry I, Smith Terry L and Cabanillas Fernando F. 20051102. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Romaguera J. E., Fayad L., Rodriguez M. A., Broglio K. R., Hagemeister F. B., Pro B., McLaughlin P., Younes A., Samaniego F., Goy A., Sarris A. H., Dang N. H., Wang M., Beasley V., Medeiros L. J., Katz R. L., Gagneja H., Samuels B. I., Smith T. L. and Cabanillas F. F. (20051102). High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Romaguera Jorge E, Fayad Luis, Rodriguez Maria A, Broglio Kristine R, Hagemeister Frederick B, Pro Barbara, McLaughlin Peter, Younes Anas, Samaniego Felipe, Goy Andre, Sarris Andreas H, Dang Nam H, Wang Michael, Beasley Virginia, Medeiros L Jeffrey, Katz Ruth L, Gagneja Harish, Samuels Barry I, Smith Terry L and Cabanillas Fernando F. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20051102.